Dr. Alberto Breda performs the world’s first transcontinental partial nephrectomy, from Bordeaux to Beijing, via tele-surgery

  • The surgery performed a week ago consisted of the removal of a kidney tumor using remote robotic surgery, conducted from Bordeaux (France) with the patient located in Beijing (China), over 8,000 km away.
  • The patient was discharged the day after the intervention and, after a week, is at home in recovery without complications.
  • Alberto Breda has marked a historic milestone during the annual European meeting on robotic surgery (ERUS), a significant advance in the field of minimally invasive surgery.
  • International experts predict that this milestone will signify the starting point for the implementation of “tele-surgery” in the coming years, also offering new applications such as collaborative surgery or distance training.

Just a week ago, on September 11, in a room at the Palais des Congrès in Bordeaux (France), Dr. Alberto Breda, head of Oncological Urology and the Renal Transplant Surgical Team at Fundació Puigvert, successfully performed the first transcontinental robotic nephrectomy from Europe to Asia. The patient, a 37-year-old man with a 3.5 cm renal tumor located 8,264 km away at the General Hospital of Beijing, was discharged the day after the intervention and, a week later, is at home in recovery without complications. Nephrectomy consists specifically of the partial or total removal of the kidney and, to reduce the likelihood of complications, it is a highly complex surgical procedure that requires urologists with advanced training and extensive experience.

“This is a historic moment that has been made possible thanks to international collaboration and also serves to illustrate the diversity that exists in the practice of modern medicine,” declares Dr. Alberto Breda. It is worth noting, in this context, that to familiarize himself with the technique and the handling of the different existing systems, in February 2024, Dr. Breda already performed a nephrectomy on a pig via tele-surgery, from Orlando (USA) to a hospital in Shanghai (China), over 12,800 km away.

On this occasion, the surgical intervention was projected onto the screens of the Bordeaux Auditorium, where the most important annual meeting on robotic surgery was held – in this 21st edition, a new record was set with over 1,000 attendees – organized by the Robotic Surgery Section of the European Association of Urology (ERUS), which Dr. Breda has presided over since 2021. Unlike surgeries that are usually broadcast live, the lead surgeon did not wear surgical clothing, but from a room controlled remotely via a console (Edge robotics system), the robotic arms intervened on the patient on the other side of the world, with a latency time of 132 milliseconds. Due to the latency time caused by the long distance, the pace of tele-surgery implementation will be conditioned by the development of 5G telecommunications networks and fiber optics, as well as the sophistication and adjustment of the different robotic systems.

According to experts present at ERUS 2024, tele-surgery will have various applications in the future, in addition to remote interventions. For example, it will allow collaborative surgery among various surgeons from different geographical locations, as well as distance training and mentoring.

There are records of two precedents of transcontinental tele-surgery: the first, in 2000, known as the “Lindbergh Operation,” from New York to a patient located in Strasbourg, performed by Dr. Jacques Marescaux. The second, more recent case, took place in July of this year, from Rome to Beijing, led by Dr. Zhang, director of the Urology Department of the Third Medical Center of the General Hospital of the People’s Liberation Army (PLA), who successfully performed the first transcontinental robotic prostatectomy.

About Alberto Breda, pioneer and international reference
in minimally invasive urological surgery

Dr. Alberto Breda is a specialist in oncological urology, particularly in kidney cancer, laparoscopic and robotic surgery. He has been a pioneer in the application of minimally invasive surgical techniques for both kidney and prostate. In 2010, Dr. Breda was the first surgeon in Spain to perform a live donor kidney extraction with the Da Vinci robot, and five years later, he was the first, along with Dr. Nicolas Doumerc in Toulouse (FR), to perform a complete robotic kidney transplant from a live donor in Europe.

He leads the Oncological Urology Unit and the Renal Transplant Surgical Team at Fundació Puigvert in Barcelona. In July 2021, he was appointed president of ERUS, the Robotic Surgery Section of the European Association of Urology (EAU), a position he will hold until 2029.

Currently, Dr. Breda is the principal investigator of several clinical trials in the field of uro-oncology. Throughout his brilliant career, he has received numerous awards and recognitions, such as the Arthur Smith Award (2016), among others. He has recently been appointed Adjunct Professor of Urology at Mount Sinai Hospital in New York and is the author of over 400 publications in indexed urological journals and 22 chapters in medical and urology books.

Press release (PDF)